Natco Pharma's Q3 Performance: Profit Surges 14.3% to ₹152 Crore, Revenue Increases 36%

Entertainment National Sports Markets Business & Economy Lifestyle World Astrology & Religion Technology Education & Jobs Auto Politics Viral Opinions

Loading more articles...

Natco Pharma Q3 Profit Jumps 14.3% to ₹152 Cr, Revenue Up 36%

Natco Pharma Q3 Profit Jumps 14.3% to ₹152 Cr, Revenue Up 36%

C

CNBC TV18•12-02-2026, 16:13

Natco Pharma Q3 Profit Jumps 14.3% to ₹152 Cr, Revenue Up 36%

•Natco Pharma reported a 14.3% YoY rise in consolidated net profit to ₹152 crore for Q3 FY26.
•Revenue from operations surged 36.3% to ₹647.3 crore, driven by export formulations.
•EBITDA soared to ₹158.7 crore from ₹39 crore, with margins improving to 24.5%.
•Export formulations contributed ₹421.4 crore, while domestic formulations added ₹119.8 crore.
•Company announced an interim dividend of ₹1.50 per share; shares trading down 1.6%.

Read Full Article on Cnbc in English

✦

More like this

✦

More like this

यह फैसला 10 फरवरी 2026 को हुई बोर्ड बैठक में लिया गया, जिसमें कंपनी के Q3 और नौ महीनों के अनऑडिटेड वित्तीय नतीजों को भी मंजूरी दी गई. बोर्ड के इस फैसले को मजबूत कैश फ्लो और वित्तीय स्थिति के संकेत के तौर पर देखा जा रहा है.

Torrent Pharma Q3 Profit Jumps 26% to ₹635 Cr, Declares ₹29 Dividend

Aurobindo Pharma Q3 Net Profit Jumps 23.31% Despite Sales Dip

Aurobindo Pharma Q3 Net Profit Jumps 23.31% Despite Sales Dip

Natco Pharma share price, Natco Pharma stock, Natco Pharma shares, Natco Pharma, Natco Pharma USFDA observations, Natco Pharma share price, Natco Pharma Chennai API Unit, Form 483 USFDA, Natco Pharma Q3 results, Natco Pharma profit, Natco Pharma revenue, Natco Pharma stock performance

Natco Pharma Shares Dip After USFDA Issues 7 Observations for Chennai Unit

Marksans Pharma Sees Strong Q3 Growth: Net Sales Up 8.93%, Profit Jumps 9.82%

Marksans Pharma Sees Strong Q3 Growth: Net Sales Up 8.93%, Profit Jumps 9.82%

Representational image (Image: News18)

GlaxoSmithKline Pharma Q3 Profit Jumps 29% to Rs 296 Cr

Torrent Pharma Shares Surge 4% on Strong Q3, JB Merger Benefits Boost Investor Confidence

Torrent Pharma Shares Surge 4% on Strong Q3, JB Merger Benefits Boost Investor Confidence